Runx1 protects against the pathological progression of osteoarthritis

Abstract

Runt-related transcription factor-1 (Runx1) is required for chondrocyte-to-osteoblast lineage commitment by enhancing both chondrogenesis and osteogenesis during vertebrate development. However, the potential role of Runx1 in joint diseases is not well known. In the current study, we aimed to explore the role of Runx1 in osteoarthritis induced by anterior cruciate ligament transaction (ACLT) surgery. We showed that chondrocyte-specific Runx1 knockout (Runx1 ^f/f Col2a1-Cre) aggravated cartilage destruction by accelerating the loss of proteoglycan and collagen II in early osteoarthritis. Moreover, we observed thinning and ossification of the growth plate, a decrease in chondrocyte proliferative capacity and the loss of bone matrix around the growth plate in late osteoarthritis. We overexpressed Runx1 by adeno-associated virus (AAV) in articular cartilage and identified its protective effect by slowing the destruction of osteoarthritis in cartilage in early osteoarthritis and alleviating the pathological progression of growth plate cartilage in late osteoarthritis. ChIP-seq analysis identified new targets that interacted with Runx1 in cartilage pathology, and we confirmed the direct interactions of these factors with Runx1 by ChIP-qPCR. This study helps us to understand the function of Runx1 in osteoarthritis and provides new clues for targeted osteoarthritis therapy.

References

[1] Klco JM, Mullighan CG. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat. Rev. Cancer, 2021, 21: 122-137

[2] Blyth K, Cameron ER, Neil JC. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer, 2005, 5: 376-387

[3] Wang Q et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA., 1996, 93: 3444-3449

[4] Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation, 2013, 128: 388-400

[5] Levanon D et al. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech. Dev., 2001, 109: 413-417

[6] Riddell A et al. RUNX1: an emerging therapeutic target for cardiovascular disease. Cardiovasc. Res., 2020, 116: 1410-1423

[7] Lian JB et al. Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo. J. Cell. Physiol., 2003, 196: 301-311

[8] Kawaguchi J, Mee PJ, Smith AG. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone, 2005, 36: 758-769

[9] Luo Y et al. Runx1 regulates osteogenic differentiation of BMSCs by inhibiting adipogenesis through Wnt/beta-catenin pathway. Arch. Oral. Biol., 2019, 97: 176-184

[10] Wang Y et al. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. J. Bone Miner. Res., 2005, 20: 1624-1636

[11] Kimura A et al. Runx1 and Runx2 cooperate during sternal morphogenesis. Development, 2010, 137: 1159-1167

[12] Tang CY et al. Runx1 up-regulates chondrocyte to osteoblast lineage commitment and promotes bone formation by enhancing both chondrogenesis and osteogenesis. Biochem. J., 2020, 477: 2421-2438

[13] Tang J et al. Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation. J. Biol. Chem., 2020, 295: 11669-11681

[14] McCarroll CS et al. Runx1 deficiency protects against adverse cardiac remodeling after myocardial infarction. Circulation, 2018, 137: 57-70

[15] Levanon D, Groner Y. Structure and regulated expression of mammalian RUNX genes. Oncogene, 2004, 23: 4211-4219

[16] Yokomizo-Nakano T, Sashida G. Two faces of RUNX3 in myeloid transformation. Exp. Hematol., 2021, 97: 14-20

[17] Krishnan V, Ito Y. A regulatory role for RUNX1, RUNX3 in the maintenance of genomic integrity. Adv. Exp. Med. Biol., 2017, 962: 491-510

[18] Otto F et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 1997, 89: 765-771

[19] Levanon D et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. Embo. J., 2002, 21: 3454-3463

[20] Yoshida CA et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev., 2004, 18: 952-963

[21] Tang CY et al. Runx1 is a central regulator of osteogenesis for bone homeostasis by orchestrating BMP and WNT signaling pathways. PLoS Genet., 2021, 17: e1009233

[22] McHugh J. Osteoarthritis risk factors differ between sexes. Nat. Rev. Rheumatol., 2021, 17: 312

[23] Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat. Rev. Rheumatol., 2021, 17: 47-57

[24] Xie J, Zhang D, Lin Y, Yuan Q, Zhou X. Anterior cruciate ligament transection-induced cellular and extracellular events in menisci: implications for osteoarthritis. Am. J. Sports Med., 2018, 46: 1185-1198

[25] Mariani E, Pulsatelli L, Facchini A. Signaling pathways in cartilage repair. Int. J. Mol. Sci., 2014, 15: 8667-8698

[26] Kwon TG et al. Physical and functional interactions between Runx2 and HIF-1alpha induce vascular endothelial growth factor gene expression. J. Cell Biochem., 2011, 112: 3582-3593

[27] Soung do Y et al. Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation. J. Bone Miner. Res., 2007, 22: 1260-1270

[28] Deng ZH, Li YS, Gao X, Lei GH, Huard J. Bone morphogenetic proteins for articular cartilage regeneration. Osteoarthr. Cartil., 2018, 26: 1153-1161

[29] Venezian R, Shenker BJ, Datar S, Leboy PS. Modulation of chondrocyte proliferation by ascorbic acid and BMP-2. J. Cell Physiol., 1998, 174: 331-341

[30] Kameda T, Koike C, Saitoh K, Kuroiwa A, Iba H. Analysis of cartilage maturation using micromass cultures of primary chondrocytes. Dev. Growth Differ., 2000, 42: 229-236

[31] Nishida Y, Knudson CB, Knudson W. Osteogenic Protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis. Osteoarthr. Cartil., 2004, 12: 374-382

[32] Shao Y et al. BMP5 silencing inhibits chondrocyte senescence and apoptosis as well as osteoarthritis progression in mice. Aging, 2021, 13: 9646-9664

[33] Yoon BS et al. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development, 2006, 133: 4667-4678

[34] Howell GR et al. Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) causes specific skeletal homeotic transformations. Genetics, 2007, 175: 699-707

[35] Symoens S et al. Genetic defects in TAPT1 disrupt ciliogenesis and cause a complex lethal osteochondrodysplasia. Am. J. Hum. Genet., 2015, 97: 521-534

[36] Unlu G et al. Phenome-based approach identifies RIC1-linked Mendelian syndrome through zebrafish models, biobank associations and clinical studies. Nat. Med., 2020, 26: 98-109

[37] Chen H, Li J, Zhang D, Zhou X, Xie J. Role of the fibroblast growth factor 19 in the skeletal system. Life Sci., 2021, 265: 118804

[38] Ellman MB, An HS, Muddasani P, Im HJ. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene, 2008, 420: 82-89

[39] Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin. Orthop. Relat. Res., 2011, 469: 2706-2715

[40] Soung do Y. Runx1-mediated regulation of osteoclast differentiation and function. Mol. Endocrinol., 2014, 28: 546-553

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81771047)